After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Lyell Immunopharma Inc is $129.33M. A total of 0.86 million shares were traded on the day, compared to an average of 734.63K shares.
In the most recent transaction, BRAWLEY OTIS W bought 35,640 shares of LYEL for 0.56 per share on Mar 31 ’25. After the transaction, the Director now owns 35,640 company shares. In a previous transaction on Mar 21 ’25, Ramachandra Sumant bought 200,000 shares at 0.58 per share. LYEL shares that Director owns now total 200,000.
Among the insiders who bought shares, Klausner Richard acquired of 158,000 shares on Mar 14 ’25 at a per-share price of $0.60. This resulted in the Director holding 843,365 shares of LYEL after the transaction. In another insider transaction, Newton Charles W. bought 200,000 shares at $0.56 per share on Mar 17 ’25. Company shares held by the Chief Financial Officer now total 200,000.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, LYEL has a high of $2.80 and a low of $0.39.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. LYEL’s latest balance sheet shows that the firm has $614.79M in Cash & Short Term Investments as of fiscal 2021. There were $67.82M in debt and $46.74M in liabilities at the time. Its Book Value Per Share was $1.14, while its Total Shareholder’s Equity was $929.79M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for LYEL is Buy with a score of 2.75.
